Lec17 Transplan Immunology Flashcards

1
Q

Isograft

A
  • transplant to self
  • identical twins
  • inbred mice
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Allograft

A
  • transplant between individuals of same species
  • rapid rejection by naive mice/human
  • alloimmunity from allloreactive B and T cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Xenograft

A
  • between species [ex. pig and human]

- rapid rejection by naive mice/human

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

HLA inheritance

A

co-dominance because inherited as haplotypes

1 in 4 chance that new sibling will have same HLA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Early inflammation posttransplant

A
  • ischemia and reperfersion and surgical trauma, as cell dies releases lots of antigens and creates damage associated molecular patterns [DAMPS]
  • leads to ROS production, complement and TLR stimulation
  • neutrophil infiltration ,organ damage
  • makes organ more susceptible to immune mediated damage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the targets of transplant immunity

A
  • HLA

- minor histocompatibility antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are alloreactive antibodies? How do they develop?

A
  • antibodies that generally recognize exposed region of MHC [HLA] molec
  • develop open exposure to alloantigens during pregnancy, blood transfusion, previous transplant, or cross-reactivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are alloreactive T cells

A
  • CD4 and CD8 T cells recognize donor MHC
  • ability to recognize donor MHC due to chance cross reactivity because recipient T cells were never trained to recognize foreign MHC molec
  • by direct or indirect reognition
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Whats the difference between direct and indirect recognition of Alloreactive T cells

A

Direct: T cell binds directly to MHC + peptide presented by donor APC that it recognizes
- rxn involves donor APC/MHC/peptide and recipient T cell

Indirect: Donor antigen taken up by recipient APC and expressed on recipient APC surface for T
- rxn involves donor peptide expressed on recipient APC/MHC and recipient T cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the reason why MHC matched donor/recipient may still have graft rejection?

A

minor histocompatibility antigens present other than just MHC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why is male-female transplant difficult?

A
  • males have some proteins made only on Y chromosome
  • these are not expressed in female so female does not have tolerance to them
  • if woman receives man’s you get immune reaction and rejection
  • ex: Smcy, Uty
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do B cells get activated by alloantigen?

A
  • same as normal process

- alloantigen binds BCR, get signal through IgM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How are T cells activated by alloantigen?

A
  • same as normal immune response

- TCR minds MHC for signal 1, CD28/B7 and CD40L/CD40 for signal 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is effect of calcineurin blocking on T cell activation in alloantigenic response?

A
  • get block of T cell activation

- calcineurin is part of signalling pathway for stimulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is Il-2 role in T cell stimulation?

A
  • released from T cell when activated

- then binds back in autocrine manner and stimulates T cell differentiation and proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is effect of anti-CD25 in T cell activation?

A
  • anti-CD25 binds and blocks IL-2 from re-binding T cell and causing activation
17
Q

Effector function of alloantibodies

A
  • anti-HLA antibody binds donor HLA on surface [type II hypersensitivity]
  • Fc receptor gamma mediates binding
  • get complement cascase activation
  • may lose endothelial cells –> thrombosis
18
Q

How to treat antibody mediated vascularized rejection [acute or hyperacute]

A

Block complement activtaion

19
Q

3 Effector mech of T cells

A
  • primed T cels produce cytokines that amplify immune response
  • Delayed Type hypersensitivity [IV]: macrophage activation, release cytokins, TNF
  • cytotoxicity
20
Q

What is thought to be pathway for acute cellular rejection?

A

T cells responding through direct pathway

21
Q

What are perforin and granzyme B?

A

cytotoxic molec from CTL that attack allogeneic target cell

22
Q

Is immunosuppression specific or non-specific?

A

Non-specific [all cells suppressed]

23
Q

What type of cells does immunosuppression usually target?

A

T cells [not B cells]

24
Q

What is most common side effect of immunosuppresion?

A

Infection

25
Q

What are 4 common drugs for immunosuppression

A
  • cyclosporine
  • steroids
  • sirolimus
  • mycophenolate mofetil azathioprine
26
Q

How do you diagnose acute cellular rejection?

A
  • diagnosed by decrease kidney function, high serum creatinine and renal biospy
27
Q

What cells are involved in acute cellular rejection

A
  • mononuclear cells
  • T cells
  • macrophages
  • anitbodies can also contribute
28
Q

How to treat acute cellular rejection? Is it reversible?

A

By increasing immunosuppresion

YES!

29
Q

What is effect on kidney of chronic rejection?

A
  • kidney fibrosis, develops after 2-3 yrs
30
Q

What is thoguht to be cause of late graft failure?

A
  • underimmunosuppresion
31
Q

What is actively acquire tolerance of foreign cells?

A
  • inject fetal mice with cells from other strain of mouse
  • later in adulthood place skin graft from donor onto tolerized recipients
  • grafts from cell donor strain last indefinietly
  • grafts from another strain rejected
  • only works if cells transferred in utero
32
Q

What are 3 current methods for acquired transplant tolerance

A
  • give bonemarrow cells from donor along with the graft
  • block costimulatory [CD28/B7] signals
  • expand regulatory T cells and give them to patients